Already shipping, already regulated, already pulled by 250+ clinicians. The next phase compiles the proprietary backbone and ships the wedge product across UK and GCC.
The next major release of the live scribe — thirteen specialty consoles, vision-enabled, multilingual, expanded EHR push, and the structured-data ingest that feeds the proprietary backbone at production volume.
Each stage funds the next. We're not asking investors to underwrite year three — we're asking them to underwrite the proof points that unlock it.
ClinixSummary & ClinixQM in active use. MHRA Class I in hand. 250+ paying clinicians.
Multi-specialty, vision-enabled, multilingual. Structured-data feed for the proprietary backbone.
Commercial alpha of the clinician-facing decision-support layer. UK + GCC pilots.
Sovereign inference, broader EHR integration and additional product surfaces opening sequentially.
Nov 2024 → June 2026. From idea to ClinixSummary live to ClinixQM live to v2 launch — entirely organic.
The idea takes shape — a medical-native intelligence ecosystem rather than another single-purpose tool.
First developer onboarded. MVP build starts focused on real-time clinical documentation.
MVP launched on iOS & Android. Zero marketing spend — users find it organically.
The quality management platform goes live at clinixqm.gacrux.ai. Two products in market, validated product-market fit.
The next major release — thirteen specialty consoles, vision-enabled, multilingual, EHR push, and the structured-data ingest that feeds the proprietary backbone.
Bootstrapped to $40M scenarios, monthly projections through 2028, use of funds, valuation framework and EHR-path detail — all available to verified investors on request.